U.S. markets closed
  • S&P Futures

    4,429.00
    -4.00 (-0.09%)
     
  • Dow Futures

    34,739.00
    -4.00 (-0.01%)
     
  • Nasdaq Futures

    15,165.00
    -29.75 (-0.20%)
     
  • Russell 2000 Futures

    2,275.60
    -1.40 (-0.06%)
     
  • Crude Oil

    75.59
    +0.14 (+0.19%)
     
  • Gold

    1,752.40
    +0.40 (+0.02%)
     
  • Silver

    22.64
    -0.05 (-0.24%)
     
  • EUR/USD

    1.1693
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    1.4840
    +0.0240 (+1.64%)
     
  • Vix

    18.76
    +1.01 (+5.69%)
     
  • GBP/USD

    1.3699
    -0.0005 (-0.04%)
     
  • USD/JPY

    111.0900
    +0.1120 (+0.10%)
     
  • BTC-USD

    42,592.46
    -1,641.55 (-3.71%)
     
  • CMC Crypto 200

    1,054.43
    -47.09 (-4.28%)
     
  • FTSE 100

    7,063.40
    +11.92 (+0.17%)
     
  • Nikkei 225

    30,015.69
    -224.37 (-0.74%)
     

Convey Announces Advisory Services Management Update

  • Oops!
    Something went wrong.
    Please try again later.
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FORT LAUDERDALE, Fla., June 28, 2021 /PRNewswire/ -- Convey Holding Parent, Inc. (NYSE: CNVY) ("Convey"), a leading healthcare technology and services company, today announced that Arjun Aggarwal is moving into an advisory role for Convey and joining Rubicon Founders ("Rubicon") as an Operating Partner. Arjun was previously the co-head of Convey's Advisory Services segment alongside Kyle Stern, who will become sole head of the Advisory Services segment and lead over 130 full time advisors for Medicare Advantage plans.

(PRNewsfoto/Convey Health Solutions)
(PRNewsfoto/Convey Health Solutions)

Stephen Farrell, CEO of Convey, commented, "I am excited to continue our relationship with Arjun as an advisor, investor and industry partner to Convey." We are grateful for his contributions and look forward to working closely with him and Rubicon going forward."

Rubicon was founded by Adam Boehler, former Director of the Center for Medicare and Medicaid Innovation at the Centers for Medicare and Medicaid Services.

Adam Boehler commented, "Rubicon is focused on building and growing transformational healthcare companies and wants entrepreneurial partners like Convey to provide technology and advice. I am looking forward to partnering with Arjun and to continue to develop our relationship with Convey."

Arjun Aggarwal said, "I look forward to driving future success as I continue my partnership with Convey in both my advisory and Rubicon roles."

Mr. Farrell continued, "We are focused on driving shareholder returns by increasing revenue, earnings, and cash flow from operations. We achieved $59.6 million of Adjusted EBITDA and $0.5 million net loss from continuing operations in the twelve months ended March 31, 2021, and are targeting long-term revenue growth in excess of 15% annually and long-term Adjusted EBITDA growth in excess of 20% annually. As a sign of senior management's commitment and confidence, we purchased over $1.9 million in stock on June 18, 2021."

About Convey

Convey is a specialized healthcare technology and services company that is committed to providing clients with healthcare-specific, compliant member support solutions utilizing technology, engagement, and analytics. Convey's administrative solutions for government-sponsored health plans help to optimize member interactions, ensure compliance, and support end-to-end Medicare processes. By combining its purpose-built technology platforms with dedicated and flexible business process solutions, Convey creates better business results and better healthcare consumer experiences on behalf of business customers and partners. Convey's clients include some of the nation's leading health insurance plans and pharmacy benefit management firms. Convey's healthcare-focused teams help millions of Americans navigate the complex Medicare Advantage and Part D landscape.

Non-GAAP Financial Measure

The non-GAAP financial measure shown in this press release excludes various items detailed further below.

We define EBITDA as net loss from continuing operations adjusted for depreciation and amortization, net interest expense and income tax provision. We define Adjusted EBITDA as EBITDA further adjusted for certain items of a significant or unusual nature, including change in fair value of contingent consideration, cost of COVID-19, non-cash stock compensation expense, transaction related costs and certain other costs.

A reconciliation of Adjusted EBITDA to the most directly comparable GAAP measure is included below. Adjusted EBITDA is not calculated in accordance with, and is not an alternative for, comparable financial measures calculated in accordance with GAAP, and our calculation of Adjusted EBITDA may differ from similar non-GAAP financial measures used by other companies. Management believes that the presentation of non-GAAP results, when shown in conjunction with corresponding GAAP measures, provides useful information to management and investors regarding financial and business trends related to Convey's operating results.

Reconciliation to Adjusted EBITDA


For the twelve
months ended March
31, 2021


(In Millions)

Net loss from continuing operations

(0.5)

Depreciation and amortization

28.6

Interest expense, net

20.1

Income tax provision

(1.6)

EBITDA, excluding discontinuing operations

$ 46.6



Other Adjustments


Change in fair value of contingent consideration

(10.8)

Cost of COVID-19

10.5

Non-cash stock compensation expense

4.4

Transaction related costs

4.9

HealthScape and Pareto acquisition bonus

1.7

Other*

2.3

Adjusted EBITDA

$ 59.6

* Other includes other individual immaterial adjustments related to legal fees associated with obtaining the incremental loans, contract termination costs assessed upon the early termination of a facility lease, severance costs incurred as a result of eliminating certain positions, management fees, and professional fees for assistance in the implementation of ASC 606.

Forward-Looking Statements

This press release contains forward-looking statements. Certain matters discussed in this press release, including, but not limited to, the statements regarding our intentions, beliefs or current expectations concerning, among other things, our financial performance; financial condition; operations and services; prospects; growth and strategies, are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "predict," "project," "target," "potential," "seek," "will," "would," "could," "should," "continue," "contemplate," "plan" and other words and terms of similar meaning. Any such statements, other than statements of historical fact, are based on management's current expectations, estimates, projections, beliefs and assumptions about Convey, and its industry. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond Convey's control, difficult to predict and could cause actual results to differ materially from those expected or forecasted in such forward-looking statements. Such statements speak only as of the time when made, and Convey undertakes no obligation to update any such forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Media Contact

Tom Pelegrin
Senior Vice President & Chief Revenue Officer
investorrelations@conveyhs.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/convey-announces-advisory-services-management-update-301321372.html

SOURCE Convey Health Solutions